Avidity Biosciences's market cap is currently ―. The company's EPS TTM is $-2.904; its P/E ratio is -7.93; Avidity Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.19M	$ 2.82M	$ 2.32M	$ 2.23M	$ 2.77M
Gross Profit	$ 2.19M	$ 2.82M	$ 2.32M	$ 2.23M	$ 2.77M
EBIT	$ -60.48M	$ -52.36M	$ -48.16M	$ -51.23M	$ -49.71M
EBITDA	$ -62.29M	$ -53.99M	$ -49.77M	$ -52.37M	$ -50.10M
Net Income Common Stockholders	$ -60.48M	$ -52.36M	$ -47.02M	$ -51.23M	$ -49.71M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 595.35M	$ 542.58M	$ 576.50M	$ 118.71M	$ 340.40M
Total Assets	$ 628.55M	$ 573.16M	$ 610.78M	$ 613.98M	$ 638.80M
Total Debt	$ 9.85M	$ 10.58M	$ 9.51M	$ 477.69M	$ 281.02M
Net Debt	$ -585.50M	$ -532.00M	$ -566.99M	$ 358.99M	$ -59.38M
Total Liabilities	$ 127.79M	$ 55.70M	$ 51.61M	$ 55.06M	$ 60.73M
Stockholders Equity	$ 500.76M	$ 517.47M	$ 559.14M	$ 558.91M	$ 578.08M
Cash Flow	-
Free Cash Flow	$ 15.64M	$ -37.69M	$ -50.46M	$ -50.78M	$ -40.04M
Operating Cash Flow	$ 16.50M	$ -36.77M	$ -49.84M	$ -48.96M	$ -39.19M
Investing Cash Flow	$ 51.04M	$ -31.48M	$ 46.05M	$ -195.68M	$ -7.77M
Financing Cash Flow	$ 31.89M	$ 40.00K	$ 38.97M	$ 22.96M	$ 243.65M

Currency in USD

Avidity Biosciences Earnings and Revenue History

Income Statement >

Avidity Biosciences Debt to Assets

Balance Sheet >

Avidity Biosciences Cash Flow

Cash Flow >

Avidity Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing